Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorivudine vs Acyclovir for Localized Herpes Zoster in HIV
NCT00000953Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Primary completion
- Sep 1996
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorivudine in herpes zoster (HZ), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
sorivudine
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT00000953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000953.